Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB06727ApprovedWithdrawnSmall molecule
Sparteine is a plant alkaloid derived from Cytisus scoparius and Lupinus mutabilis which may chelate calcium and magnesium. It is a sodium channel blocker, so it falls in the category... Sparteine is not currently FDA-approved for human use, and its salt, sparteine sulfate, is one of the products that have been withdrawn or removed from the market for reasons of safety or effectiveness.
- Formula / weight
- C15H26N2 · 234.387 g/mol (avg)
- Also known as
- Lupinidine
Resolves to
Clinical / RWD
Structure
InChIKey
SLRCCWJSBJZJBV-ZQDZILKHSA-NSMILES[H][C@@]12CCCCN1C[C@@H]1C[C@H]2CN2CCCC[C@]12[H]What you can answer from here — as of July 17, 2026
Which companies are running trials of Sparteine, in which indications and phases, and which of those programs are still active?